Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer

Fil: Fil: Perroud, Herman A. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; Argentina

Bibliographic Details
Authors: Perroud, Herman A, Rico, María José, Alasino, Carlos María, Pezzotto, Stella Maris, Rozados, Viviana R., Scharovsky, O. Graciela
Format: article
Status:Published version
Publication Date:2013
Country:Argentina
Institution:Universidad Nacional de Rosario
Repository:RepHipUNR (UNR)
Language:English
OAI Identifier:oai:rephip.unr.edu.ar:2133/11554
Online Access:http://hdl.handle.net/2133/11554
Access Level:Open access
Keyword:Biomarkers
Celecoxib 
Cyclophosphamide
metronomic chemotherapy
id AR_7bd7a6e8bc82f3ca7bf6af5b064fb140
oai_identifier_str oai:rephip.unr.edu.ar:2133/11554
network_acronym_str AR
network_name_str Argentina
repository_id_str
spelling Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancerPerroud, Herman ARico, María JoséAlasino, Carlos MaríaPezzotto, Stella MarisRozados, Viviana R.Scharovsky, O. GracielaBiomarkersCelecoxib Cyclophosphamidemetronomic chemotherapyFil: Fil: Perroud, Herman A. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; ArgentinaFil: Fil: Rico, María José. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; ArgentinaFil: Fil: Alasino, Carlos María. Institute of Oncology of Rosario; Rosario; Argentina.Fil: Fil: Pezzotto, Stella Maris. Research Council of the National University of Rosario (CIUNR); Rosario; Argentina.Fil: Fil: Rozados, Viviana R. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; Argentina.Fil: Fil: Scharovsky, Graciela Olga. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; Argentina.Indian Cancer Society and Indian Society of Oncology2013-08-27info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfhttp://hdl.handle.net/2133/11554urn:issn: 0019-509Xenghttp://www.indianjcancer.com/article.asp?issn=0019-509X;year=2013;volume=50;issue=2;spage=115;epage=121;aulast=Perroud10.4103/0019-509X.117031info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/4.0/Licencia RepHipreponame:RepHipUNR (UNR)instname:Universidad Nacional de Rosario2024-05-15T12:22:46Zoai:rephip.unr.edu.ar:2133/11554instacron:UNRInstitucionalhttps://rephip.unr.edu.ar/Universidad públicaNo correspondehttps://rephip.unr.edu.ar/oai/requestrephip@unr.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:15502024-05-15 12:22:46.992RepHipUNR (UNR) - Universidad Nacional de Rosariofalse
dc.title.none.fl_str_mv Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
title Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
spellingShingle Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
Perroud, Herman A
Biomarkers
Celecoxib 
Cyclophosphamide
metronomic chemotherapy
title_short Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
title_full Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
title_fullStr Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
title_full_unstemmed Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
title_sort Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer
dc.creator.none.fl_str_mv Perroud, Herman A
Rico, María José
Alasino, Carlos María
Pezzotto, Stella Maris
Rozados, Viviana R.
Scharovsky, O. Graciela
author Perroud, Herman A
author_facet Perroud, Herman A
Rico, María José
Alasino, Carlos María
Pezzotto, Stella Maris
Rozados, Viviana R.
Scharovsky, O. Graciela
author_role author
author2 Rico, María José
Alasino, Carlos María
Pezzotto, Stella Maris
Rozados, Viviana R.
Scharovsky, O. Graciela
author2_role author
author
author
author
author
dc.subject.none.fl_str_mv Biomarkers
Celecoxib 
Cyclophosphamide
metronomic chemotherapy
topic Biomarkers
Celecoxib 
Cyclophosphamide
metronomic chemotherapy
description Fil: Fil: Perroud, Herman A. Institute of Experimental Genetics. School of Medical Sciences. National University of Rosario; Rosario; Argentina
publishDate 2013
dc.date.none.fl_str_mv 2013-08-27
dc.type.none.fl_str_mv info:eu-repo/semantics/article


info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/2133/11554
urn:issn: 0019-509X
url http://hdl.handle.net/2133/11554
identifier_str_mv urn:issn: 0019-509X
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://www.indianjcancer.com/article.asp?issn=0019-509X;year=2013;volume=50;issue=2;spage=115;epage=121;aulast=Perroud
10.4103/0019-509X.117031
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/4.0/
Licencia RepHip
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/4.0/
Licencia RepHip
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Indian Cancer Society and Indian Society of Oncology
publisher.none.fl_str_mv Indian Cancer Society and Indian Society of Oncology
dc.source.none.fl_str_mv reponame:RepHipUNR (UNR)
instname:Universidad Nacional de Rosario
instname_str Universidad Nacional de Rosario
reponame_str RepHipUNR (UNR)
collection RepHipUNR (UNR)
repository.name.fl_str_mv RepHipUNR (UNR) - Universidad Nacional de Rosario
repository.mail.fl_str_mv rephip@unr.edu.ar
_version_ 1799197000983379968
score 15,812429

Similar Items